PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+2.69%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$734M
AUM Growth
-$80.8M
(-9.9%)
Cap. Flow
-$47.7M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
111
New
11
Increased
44
Reduced
34
Closed
21
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$19.2M |
| 2 |
Insulet
PODD
|
$17.8M |
| 3 |
Icon
ICLR
|
$11.6M |
| 4 |
Humana
HUM
|
$11.2M |
| 5 |
Boston Scientific
BSX
|
$9.71M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$17.9M |
| 2 |
Inspire Medical Systems
INSP
|
$17.4M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$15.6M |
| 4 |
Cencora
COR
|
$13.5M |
| 5 |
Oscar Health
OSCR
|
$12.4M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Industrials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nurix Therapeutics
NRIX
$727M
| $9.91M | 1.33% |
474,679
+224,679
| +90% | +$4.69M |
|
27
Qiagen
QGEN
$10.3B
| $9.63M | 1.29% |
227,760
-77,473
| -25% | -$3.27M |
|
|
NARI
28
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $9.42M | 1.26% |
195,567
+70,229
| +56% | +$3.38M |
|
29
Keros Therapeutics
KROS
$636M
| $9.08M | 1.22% |
198,627
+20,292
| +11% | +$927K |
|
30
Alphatec Holdings
ATEC
$2.44B
| $8.91M | 1.19% |
852,416
+515,728
| +153% | +$5.39M |
|
31
Arcellx
ACLX
$3.98B
| $8.66M | 1.16% |
156,843
+245
| +0.2% | +$13.5K |
|
|
VRNA
32
Verona Pharma
VRNA
$9.2B
| $8.61M | 1.15% |
595,389
+65,869
| +12% | +$952K |
|
33
Gilead Sciences
GILD
$142B
| $8.58M | 1.15% |
+125,000
| New | +$8.58M |
|
|
34
Cencora
COR
$56.7B
| $8.56M | 1.15% |
38,014
-59,891
| -61% | -$13.5M |
|
35
Bristol-Myers Squibb
BMY
$95.2B
| $8.31M | 1.11% |
+200,000
| New | +$8.31M |
|
36
Xenon Pharmaceuticals
XENE
$3.02B
| $8.16M | 1.09% |
209,290
-14,652
| -7% | -$571K |
|
37
Travere Therapeutics
TVTX
$1.94B
| $7.97M | 1.07% |
969,892
+1,472
| +0.2% | +$12.1K |
|
38
Ionis Pharmaceuticals
IONS
$9.76B
| $7.71M | 1.03% |
161,705
+20,206
| +14% | +$963K |
|
39
AnaptysBio
ANAB
$611M
| $6.42M | 0.86% |
+256,307
| New | +$6.42M |
|
40
Crinetics Pharmaceuticals
CRNX
$3.35B
| $6.33M | 0.85% |
141,375
+40,256
| +40% | +$1.8M |
|
41
Arcus Biosciences
RCUS
$1.25B
| $6.33M | 0.85% |
415,535
+155,615
| +60% | +$2.37M |
|
42
Haemonetics
HAE
$2.63B
| $6.29M | 0.84% |
76,079
-14,883
| -16% | -$1.23M |
|
43
Castle Biosciences
CSTL
$677M
| $6.05M | 0.81% |
277,895
-89,513
| -24% | -$1.95M |
|
44
Teva Pharmaceuticals
TEVA
$21.5B
| $5.75M | 0.77% |
353,942
-99,648
| -22% | -$1.62M |
|
45
Ironwood Pharmaceuticals
IRWD
$188M
| $5.71M | 0.77% |
876,268
+26,268
| +3% | +$171K |
|
|
SLN
46
Silence Therapeutics
SLN
$256M
| $5.51M | 0.74% |
289,841
+45,370
| +19% | +$862K |
|
47
Insmed
INSM
$29.9B
| $5.38M | 0.72% |
80,271
-12,761
| -14% | -$855K |
|
48
CVRx
CVRX
$203M
| $5.37M | 0.72% |
447,620
+115,530
| +35% | +$1.39M |
|
49
Applied Therapeutics
APLT
$68.8M
| $5.36M | 0.72% |
1,148,307
-706,456
| -38% | -$3.3M |
|
|
AVDL
50
Avadel Pharmaceuticals
AVDL
$1.48B
| $5.32M | 0.71% |
378,289
-9,481
| -2% | -$133K |
|